Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce L Levine

Showing results (1-10 of 185) with videos related to

Pageof 19
Sort By:
Expert Opinion on Biological Therapy|March 21, 2008
T lymphocyte engineering ex vivo for cancer and infectious diseaseBruce L Levine
Human Vaccines & Immunotherapeutics|September 26, 2017
Exploring synthetic immunity: From boutique to globalBruce L Levine
Annals of Translational Medicine|February 9, 2016
Smart CARS: optimized development of a chimeric antigen receptor (CAR) T cell targeting epidermal growth factor receptor variant III (EGFRvIII) for glioblastomaMarco Ruella, Bruce L Levine
Regenerative Medicine|December 6, 2012
Convergence of gene and cell therapyAlexey Bersenev, Bruce L Levine
Haematologica|October 2, 2008
Adoptive T-cell therapy for malignant disordersDaniel J Powell, Bruce L Levine
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 30, 2015
T cell engineering as therapy for cancer and HIV: our synthetic futureCarl H June, Bruce L Levine
Nature|June 28, 2013
Perspective: assembly line immunotherapyBruce L Levine, Carl H June
The Oncologist|March 25, 2016
Chimeric Antigen Receptor T-Cell Therapy for the Community OncologistMarcela V Maus, Bruce L Levine
Cytotherapy|April 9, 2013
Innovation and opportunity for chimeric antigen receptor targeted T cellsJ Joseph Melenhorst, Bruce L Levine
Nature Biomedical Engineering|April 25, 2019
Powered and controlled T-cell productionMichael C Milone, Bruce L Levine
Pageof 19

Showing results (1-10 of 185) with videos related to

Sort By:
Pageof 19
Expert Opinion on Biological Therapy|March 21, 2008
T lymphocyte engineering ex vivo for cancer and infectious diseaseBruce L Levine
Human Vaccines & Immunotherapeutics|September 26, 2017
Exploring synthetic immunity: From boutique to globalBruce L Levine
Annals of Translational Medicine|February 9, 2016
Smart CARS: optimized development of a chimeric antigen receptor (CAR) T cell targeting epidermal growth factor receptor variant III (EGFRvIII) for glioblastomaMarco Ruella, Bruce L Levine
Regenerative Medicine|December 6, 2012
Convergence of gene and cell therapyAlexey Bersenev, Bruce L Levine
Haematologica|October 2, 2008
Adoptive T-cell therapy for malignant disordersDaniel J Powell, Bruce L Levine
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 30, 2015
T cell engineering as therapy for cancer and HIV: our synthetic futureCarl H June, Bruce L Levine
Nature|June 28, 2013
Perspective: assembly line immunotherapyBruce L Levine, Carl H June
The Oncologist|March 25, 2016
Chimeric Antigen Receptor T-Cell Therapy for the Community OncologistMarcela V Maus, Bruce L Levine
Cytotherapy|April 9, 2013
Innovation and opportunity for chimeric antigen receptor targeted T cellsJ Joseph Melenhorst, Bruce L Levine
Nature Biomedical Engineering|April 25, 2019
Powered and controlled T-cell productionMichael C Milone, Bruce L Levine
Pageof 19